Peptide ScheduleEpithalon
Benefits
About Epithalon
Epithalon (Epitalon) is a tetrapeptide that activates telomerase, the enzyme responsible for lengthening telomeres — the protective caps on chromosomes that shorten with age. Developed by Dr. Vladimir Khavinson, who studied it for over 20 years, it's used in short, intensive cycles to promote cellular age reversal. Research shows it can increase telomere length, normalize melatonin production, and improve overall lifespan markers.
Who Should Consider Epithalon
- Adults over 40 seeking proactive aging intervention
- Individuals with shortened telomere length on testing
- Those with disrupted circadian rhythm or poor melatonin production
- Health-optimizers interested in longevity protocols
- Older adults (60+) looking to support cellular repair capacity
How Epithalon Works
Epithalon activates the enzyme telomerase, which adds TTAGGG repeats to the ends of chromosomes (telomeres). Telomere shortening is a key driver of cellular aging — when telomeres become too short, cells enter senescence or die. By reactivating telomerase, Epithalon extends cellular lifespan. It also normalizes pineal gland melatonin production, improving circadian rhythm and sleep.
What to Expect
Initial loading phase. No noticeable external changes. Telomerase activation begins at the cellular level. Some users report improved sleep quality within the first few days due to melatonin normalization.
Mid-cycle. Sleep improvements become more consistent. Subtle increases in energy and mental clarity reported by some users. Telomere elongation processes are underway but not yet measurable.
End of active cycle. Cumulative telomerase activation reaches peak effect. Users commonly note improved sleep architecture, better recovery, and a general sense of well-being.
Effects persist after stopping. Telomere length gains from the active cycle are maintained. Melatonin normalization continues. No injections during this period.
Long-lasting cellular benefits continue. Telomere length can be retested to confirm gains. Plan next 10-20 day cycle. Most protocols call for 2-3 cycles per year.
Dosing Protocol
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 5mg | Daily |
| Moderate | 10mg | Daily |
| Aggressive | 10mg | Daily |
Note: Telomerase activator. Run in short cycles: 5-10mg daily for 10-20 days, then off for 4-6 months. Based on research by Dr. Vladimir Khavinson. Store reconstituted vial refrigerated.
How to Inject Epithalon
Inject subcutaneously or intramuscularly once daily, typically before bed to synergize with natural melatonin release. Abdomen or deltoid are common sites.
Cycling Protocol
Run 10-20 day intensive cycles, then off for 4-6 months. Effects persist long after the cycle ends. Most users do 2-3 cycles per year.
Pharmacokinetics
Source: Estimated from tetrapeptide class PK data; rapid peptidase degradation (Khavinson et al.); no formal human PK study published
Pharmacokinetics — Active Dose Over Time
t½ = ~30 minutes (plasma)Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
Side Effects
Very well-tolerated. Occasional injection site irritation. Improved sleep quality may be noticeable within days.
Contraindications
- Pregnancy or breastfeeding
- Active cancer or history of cancer (telomerase activation may theoretically promote tumor cell survival)
- Known hypersensitivity to Epithalon or any of its amino acid components
- Autoimmune conditions — use with caution and medical supervision
- Children and adolescents (insufficient safety data)
Drug Interactions
- Immunosuppressants — Epithalon may modulate immune function; monitor closely if on cyclosporine, tacrolimus, or similar agents
- Melatonin supplements — Epithalon normalizes endogenous melatonin; exogenous melatonin dosing may need adjustment
- Chemotherapy or anti-cancer agents — telomerase activation could theoretically interfere with treatments targeting telomerase in tumor cells
- Sedatives and sleep medications — improved melatonin output may potentiate sedative effects
Storage & Stability
Molecular Profile
Related Peptides
References
- Epithalon Peptide Induces Telomerase Activity and Telomere Elongation in Human Somatic Cells (Bull Exp Biol Med 2003)PubMed 12937682
- Epitalon Increases Telomere Length in Human Cell Lines Through Telomerase Upregulation or ALT Activity (2025)PubMed 40908429
- Overview of Epitalon — Highly Bioactive Pineal Tetrapeptide with Promising Properties (Int J Mol Sci 2025)PubMed 40141547
- Peptide Regulation of Gene Expression and Protein Synthesis in Bronchial Epithelium — Khavinson (Lung 2008)PubMed 18066623